Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03499899
Title A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL | AUS

Facility Status City State Zip Country Details
Ironwood Cancer and Research Centers Chandler Arizona 85224 United States Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
Novartis Investigative Site Caba Buenos Aires C1280AEB Argentina Details
Novartis Investigative Site Wooloongabba Queensland 4102 Australia Details
Novartis Investigative Site Melbourne Victoria 3000 Australia Details
Novartis Investigative Site Nedlands Western Australia 6009 Australia Details
Novartis Investigative Site Liege 4000 Belgium Details
Novartis Investigative Site Montreal Quebec H3T 1E2 Canada Details
Novartis Investigative Site Quebec G1S 4L8 Canada Details
Novartis Investigative Site Paris 75231 France Details
Novartis Investigative Site Luebeck Schleswig-holstein 23563 Germany Details
Novartis Investigative Site Erlangen 91054 Germany Details
Novartis Investigative Site Tübingen 72076 Germany Details
Novartis Investigative Site Budapest H 1122 Hungary Details
Novartis Investigative Site Szeged H-6720 Hungary Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Napoli 80131 Italy Details
Novartis Investigative Site Nagoya-city Aichi 467-8602 Japan Details
Novartis Investigative Site Nagoya Aichi 466 8560 Japan Details
Novartis Investigative Site Yokohama-city Kanagawa 241-8515 Japan Details
Novartis Investigative Site Minato ku Tokyo 105-8470 Japan Details
Novartis Investigative Site Seoul Korea 05505 Korea, Republic of Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Ashrafieh 166830 Lebanon Details
Novartis Investigative Site El Metn Lebanon Details
Novartis Investigative Site Saida 652 Lebanon Details
Novartis Investigative Site Singapore 169610 Singapore Details
Novartis Investigative Site Sevilla Andalucia 41013 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Taipei 10002 Taiwan Details
Novartis Investigative Site Taipei 11217 Taiwan Details
Novartis Investigative Site Taipei Taiwan Details
Novartis Investigative Site Songkla 90110 Thailand Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field